Comprehensive analysis identifies CLEC1B as a potential prognostic biomarker in hepatocellular carcinoma

Comprehensive analysis identifies CLEC1B as a potential prognostic biomarker in hepatocellular carcinoma

Abstract Background C-type lectin domain family 1 member B (CLEC1B, encoding the CLEC-2 protein), a member of the C-type lectin superfamily, is a type II transmembrane receptor involved in platelet activation, angiogenesis, and immune and inflammatory responses. However, data regarding its function...

Full description

Bibliographic Details
Main Authors: Qiangan Jing, Chen Yuan, Chaoting Zhou, Weidong Jin, Aiwei Wang, Yanfang Wu, Wenzhong Shang, Guibing Zhang, Xia Ke, Jing Du, Yanchun Li, Fangchun Shao
Format: Article
Language:English
Published: BMC 2023-06-01
Series:Cancer Cell International
Subjects:
CLEC1B
Hepatocellular carcinoma
Tumor microenvironment
Immunoregulator
Sorafenib
Biomarker
Online Access:https://doi.org/10.1186/s12935-023-02939-1

Internet

https://doi.org/10.1186/s12935-023-02939-1

Similar Items